AH
Andreessen Horowitz (a16z) Bio + Health
Andreessen Horowitz (a16z) Bio + Health focuses on investing in therapeutic platforms and cutting-edge technology companies that leverage the convergence of AI, technology, and biology to drive transformative progress in human health. Their strategy involves backing entrepreneurs across all stages, from company creation to growth, to build a modern, efficient, and enduring healthcare system that improves patient care and addresses systemic challenges.
Portfolio
2
Fund Size
$700M
Top Stage
Series B
Last 12 Mo
2
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Gate Bioscience | Series B | $65M | Nov 2025 |
| Sprinter Health | Series B | $55M | May 2025 |
Top Co-Investors
GV (Google Ventures)2 shared
Forbion1 shared
Eli Lilly and Company1 shared
Versant Ventures1 shared
ARCH Venture Partners1 shared
General Catalyst1 shared
Accel1 shared
Last updated: 1 March 2026